The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
Background:Autism spectrum disorder (ASD), a neurodevelopmental disease, is described by problems with social interaction and communication that arise at an early age. The only approved drugs for the treatment of ASD are risperidone and aripiprazole. Objectives:The aim of the article is to explore t...
Saved in:
| Main Authors: | Ahmed Sudan Abbas, Selman Mohammed Selman, Alaa Jafear Mahrath |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Series: | Medical Journal of Babylon |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/MJBL.MJBL_398_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01) -
A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01) -
Cerebroprotective prevention of memory disorders using sodium valproate
by: A. V. Ivanov
Published: (2013-04-01) -
Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate
by: Mami Uegami, et al.
Published: (2025-01-01) -
Behavioral features of Wistar rats in models of autism spectrum disorders induced by prenatal or postnatal administration of sodium valproate
by: E. V. Savinkova, et al.
Published: (2024-08-01)